NSEChange in Director(s)22 Jul 2026 · 22 Jul 2026, 07:50 pm
Change in Director(s)
Biocon Limited · BIOCON
✦ AI SummaryMgmt Change
Biocon Limited has informed the Exchange regarding Change in Director(s) of the company, specifically the completion of tenure of Independent Director Mr. Bobby Kanubhai Parikh.
Analysis Scores
Earnings Impact2/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Biocon Limited has informed the Exchange regarding Change in Director(s) of the company.
Attachments (1)
📄pdf
Download →
BIOCON_22072026194943_SE_Intimation.pdf
View document text
Biocon Limited
20th KM, Hosur Road
Electronic City
Bangalore 560 100, India
T 91 80 2808 2808
F 91 80 2852 3423
CIN : L24234KA1978PLC003417
www.biocon.com
BIO/SECL/TG/2026-27/43
July 22, 2026
To, To,
The Manager The Manager
BSE Limited National Stock Exchange of India Limited
Department of Corporate Services Corporate Communication Department
Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra Kurla Complex
Dalal Street, Mumbai – 400 001 Mumbai – 400 051
Scrip Code - 532523 Scrip Symbol – BIOCON
Dear Sir/ Madam,
Subject: Completion of tenure of Independent Director
Pursuant to Regulation 30 read with Part A of Schedule III of the Securities and Exchange Board of India
(Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’), we hereby
inform that Mr. Bobby Kanubhai Parikh (DIN: 00019437), has completed his second term as an Independent
Director and consequently ceased to be a Director of the Company w.e.f. the close of business hours of July
22, 2026. The Board of Directors of the Company places on record their deep appreciation and gratitude to
Mr. Bobby Kanubhai Parikh for his extensive contribution and stewardship.
Details required under Regulation 30 of the SEBI Listing Regulations read with SEBI Circular No.
HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, are enclosed herewith as ‘Annexure
The above information will also be available on the website of the Company at www.biocon.com.
Kindly take the above information on record and acknowledge.
Thanking You,
Yours faithfully,
For Biocon Limited
Rajesh U. Shanoy
Company Secretary and Compliance officer
ICSI Membership Number: A16328
ANNEXURE A
Details as required under the Regulation 30 of the SEBI Listing Regulations read with SEBI Circular No.
HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026:
Sl. No. Particulars Details
1. Name Bobby Kanubhai Parikh
2. Reason for change viz. appointment, re- Cessation
appointment, resignation, removal, death (Completion of second term as an Independent
or otherwise Director)
3. Date of appointment/re- With effect from close of business hours of July
appointment/cessation (as applicable) & 22, 2026
term of appointment/re-appointment
4. Brief profile Not Applicable
(in case of appointment)
5. Disclosure of relationships between Not Applicable
directors (in case of appointment of a
director)